Latest news

Nucleai and Bio-Techne Unveil Clinical Data on AI-Powered Spatial Biology for Predictive Biomarkers in Melanoma

Sifted – How AI startups working on clinical trials for cancer could find a breakthrough before big pharma

Proscia and Nucleai partner to broaden access to AI predictive biomarkers

Nucleai and GoPath Diagnostics announce strategic collaboration

Merck’s M Ventures supports Nucleai’s spatial AI biomarker technology for clinical trial enrolment

Nucleai and Altis Labs are transforming clinical trials through AI innovation

Nucleai announces strategic collaboration with Mayo Clinic BioPharma Diagnostics

Nucleai and Adlai Nortye Partner to Identify and Validate Novel Spatial Biomarkers Across Adlai Clinical Trials

Nucleai closes $33 Million Series B financing to advance its spatial biology platform for drug research, Development and diagnostics